Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 119
Filter
Add more filters










Publication year range
1.
Int J Androl ; 35(3): 424-36, 2012 Jun.
Article in English | MEDLINE | ID: mdl-22612478

ABSTRACT

Today, topical application of sunscreens, containing ultraviolet-filters (UV-filters), is preferred protection against adverse effects of ultraviolet radiation. Evidently, use of sunscreens is effective in prevention of sunburns in various models. However, evidence for their protective effects against melanoma skin cancer is less conclusive. Three important observations prompted us to review the animal data and human studies on possible side effects of selected chemical UV-filters in cosmetics. (1) the utilization of sunscreens with UV-filters is increasing worldwide; (2) the incidence of the malignant disorder for which sunscreens should protect, malignant melanoma, is rapidly increasing and (3) an increasing number of experimental studies indicating that several UV-filters might have endocrine disruptive effects. The selected UV-filters we review in this article are benzophenone-3 (BP-3), 3-benzylidene camphor (3-BC), 3-(4-methyl-benzylidene) camphor (4-MBC), 2-ethylhexyl 4-methoxy cinnamate (OMC), Homosalate (HMS), 2-ethylhexyl 4-dimethylaminobenzoate (OD-PABA) and 4-aminobenzoic acid (PABA). The potential adverse effects induced by UV-filters in experimental animals include reproductive/developmental toxicity and disturbance of hypothalamic-pituitary-thyroid axis (HPT). Few human studies have investigated potential side effects of UV-filters, although human exposure is high as UV-filters in sunscreens are rapidly absorbed from the skin. One of the UV-filters, BP-3, has been found in 96% of urine samples in the US and several UV-filters in 85% of Swiss breast milk samples. It seems pertinent to evaluate whether exposure to UV-filters contribute to possible adverse effects on the developing organs of foetuses and children.


Subject(s)
Endocrine Disruptors/pharmacology , Sunburn/prevention & control , Sunscreening Agents/adverse effects , 4-Aminobenzoic Acid/adverse effects , Animals , Benzyl Compounds/adverse effects , Camphor/adverse effects , Camphor/analogs & derivatives , Cinnamates/adverse effects , Humans , Hypothalamo-Hypophyseal System/drug effects , Melanoma/chemically induced , Receptors, Estrogen/drug effects , Salicylates/adverse effects , Skin Neoplasms/chemically induced , Skin Neoplasms/prevention & control , Thyroid Gland/drug effects , Ultraviolet Rays/adverse effects , para-Aminobenzoates
2.
Int J Androl ; 35(3): 303-16, 2012 Jun.
Article in English | MEDLINE | ID: mdl-22372636

ABSTRACT

By diminishing the action of androgens during gestation, certain chemicals can induce irreversible demasculinization and malformations of sex organs in the male rat after gestational exposure. Studies with mixtures of such anti-androgens have shown that substantial combined effects occur even though each individual chemical is present at low, ineffective doses, but the effects of mixtures modelled based on human intakes have not previously been investigated. To address this issue for the first time, we selected 13 chemicals for a developmental mixture toxicity study in rats where data about in vivo endocrine disrupting effects and information about human exposures was available, including phthalates, pesticides, UV-filters, bisphenol A, parabens and the drug paracetamol. The mixture ratio was chosen to reflect high end human intakes. To make decisions about the dose levels for studies in the rat, we employed the point of departure index (PODI) approach, which sums up ratios between estimated exposure levels and no-observed-adverse-effect-level (NOAEL) values of individual substances. For high end human exposures to the 13 selected chemicals, we calculated a PODI of 0.016. As only a PODI exceeding 1 is expected to lead to effects in the rat, a total dose more than 62 times higher than human exposures should lead to responses. Considering the high uncertainty of this estimate, experience on lowest-observed-adverse-effect-level (LOAEL)/NOAEL ratios and statistical power of rat studies, we expected that combined doses 150 times higher than high end human intake estimates should give no, or only borderline effects, whereas doses 450 times higher should produce significant responses. Experiments indeed showed clear developmental toxicity of the 450-fold dose in terms of increased nipple retention (NR) and reduced ventral prostate weight. The 150-fold dose group exhibited significantly increased NR. These observations suggest that highly exposed population groups, especially women of reproductive age, may not be protected sufficiently against the combined effects of chemicals that affect the hormonal milieu required for normal male sexual differentiation.


Subject(s)
Androgen Antagonists/toxicity , Endocrine Disruptors/toxicity , Abnormalities, Drug-Induced , Animals , Female , Genitalia/abnormalities , Humans , Male , No-Observed-Adverse-Effect Level , Pregnancy , Rats , Rats, Wistar , Sex Differentiation/drug effects
3.
Food Chem Toxicol ; 48(2): 502-8, 2010 Feb.
Article in English | MEDLINE | ID: mdl-19897005

ABSTRACT

The endocrine disrupting potential of the herbicide pendimethalin was investigated in vivo on the uterotrophic response and on the expression of estrogen-regulated genes examined by quantitative real-time RT PCR. Receptor binding characteristics of pendimethalin were analyzed by an in silico method. Pendimethalin (150, 225, 300 and 600 mg/kg/day) was administered by oral gavage to immature female rats for 3 days, with ethinylestradiol (0.001 mg/kg/day) as positive control. Pendimethalin caused a small but significant increase in absolute uterine weight at and above 300 mg/kg/day and in relative uterine weight at 600 mg/kg/day. Estrogen receptor (ER)-alpha mRNA levels were not affected, whereas ER-beta mRNA was up-regulated at the highest dose. Progesterone receptor mRNA level was not significantly changed, while insulin-like growth factor-I mRNA was reduced, significantly at 225 mg/kg/day to 65% of control. Androgen receptor (AR) mRNA showed a marked down-regulation at doses of 225 mg/kg/day and above. The expression pattern differed from that of ethinylestradiol. In silico analysis revealed potential binding of pendimethalin to ER-beta and AR, but virtually no binding to ER-alpha. These data demonstrate that pendimethalin exhibits estrogenic activity also in vivo. However, its uterotrophic effect, which is an ER-alpha-mediated response, is very small, and it appears that in vivo actions should rather be sought in ER-beta-regulated functions.


Subject(s)
Aniline Compounds/toxicity , Endocrine Disruptors/toxicity , Gene Expression Regulation/drug effects , Herbicides/toxicity , Receptors, Steroid/drug effects , Uterus/drug effects , Animals , Binding Sites/drug effects , Body Weight/drug effects , Computational Biology , Estrogen Receptor beta/drug effects , Estrogen Receptor beta/genetics , Estrogen Receptor beta/metabolism , Female , Gene Expression Profiling , Organ Size/drug effects , RNA, Messenger/metabolism , Rats , Rats, Long-Evans , Receptors, Steroid/genetics , Receptors, Steroid/metabolism , Up-Regulation/drug effects , Uterus/metabolism
4.
Anticancer Res ; 28(1A): 85-9, 2008.
Article in English | MEDLINE | ID: mdl-18383828

ABSTRACT

BACKGROUND: Delta(9)-tetrahydrocannabinol (THC) exerts palliative effects in cancer patients, but produces adverse effects on the endocrine and reproductive systems. Experimental evidence concerning such effects is controversial. Whether THC exhibits estrogenic or androgenic activity in vitro was investigated. MATERIALS AND METHODS: Estrogenic effects of THC were analyzed in vitro by measuring the proliferation of estrogen-sensitive MCF7 cells. Androgenic activity was investigated by the A-Screen assay that measures androgen-dependent inhibition of proliferation of the androgen receptor (AR)-positive human mammary carcinoma cell line, MCF7-AR1. RESULTS: In contrast to 17beta-estradiol, included as positive control with an EC50 value (concentration required for 50% of maximal 17beta-estradiol-induced proliferation) of 1.00 x 10(-12) M, THC failed to induce cell proliferation in the MCF7 cell line at concentrations between 10(-13) and 10(-4) M. THC inhibited 17beta-estradiol-induced proliferation in wild-type MCF7 and MCF7-AR1 cells, with an IC50 value of 2.6 x 10(-5) M and 9 x 10(-6) M, respectively. CONCLUSION: THC failed to act as an estrogen, but antagonized 17beta-estradiol-induced proliferation. This effect was independent of the AR expression level.


Subject(s)
Breast Neoplasms/pathology , Dronabinol/pharmacology , Estradiol/pharmacology , Estrogen Antagonists/pharmacology , Receptors, Androgen/metabolism , Receptors, Estrogen/metabolism , Breast Neoplasms/drug therapy , Breast Neoplasms/metabolism , Cell Growth Processes/drug effects , Cell Line, Tumor , Drug Interactions , Humans , Receptors, Androgen/biosynthesis , Receptors, Estrogen/biosynthesis
5.
Environ Health Perspect ; 109(3): 239-44, 2001 Mar.
Article in English | MEDLINE | ID: mdl-11333184

ABSTRACT

Ultraviolet (UV) screens are increasingly used as a result of growing concern about UV radiation and skin cancer; they are also added to cosmetics and other products for light stability. Recent data on bioaccumulation in wildlife and humans point to a need for in-depth analyses of systemic toxicology, in particular with respect to reproduction and ontogeny. We examined six frequently used UVA and UVB screens for estrogenicity in vitro and in vivo. In MCF-7 breast cancer cells, five out of six chemicals, that is, benzophenone-3 (Bp-3), homosalate (HMS), 4-methyl-benzylidene camphor (4-MBC), octyl-methoxycinnamate (OMC), and octyl-dimethyl-PABA (OD-PABA), increased cell proliferation with median effective concentrations (EC(50)) values between 1.56 and 3.73 microM, whereas butyl-methoxydibenzoylmethane (B-MDM) was inactive. Further evidence for estrogenic activity was the induction of pS2 protein in MCF-7 cells and the blockade of the proliferative effect of 4-MBC by the estrogen antagonist ICI 182,780. In the uterotrophic assay using immature Long-Evans rats that received the chemicals for 4 days in powdered feed, uterine weight was dose-dependently increased by 4-MBC (ED(50 )309mg/kg/day), OMC (ED(50) 935 mg/kg/day), and weakly by Bp-3 (active at 1,525 mg/kg/day). Three compounds were inactive by the oral route in the doses tested. Dermal application of 4-MBC to immature hairless (hr/hr) rats also increased uterine weight at concentrations of 5 and 7.5% in olive oil. Our findings indicate that UV screens should be tested for endocrine activity, in view of possible long-term effects in humans and wildlife.


Subject(s)
Estradiol Congeners/pharmacology , Receptors, Estrogen/drug effects , Sunscreening Agents/pharmacology , Ultraviolet Rays , Uterus/drug effects , Animals , Benzophenones/pharmacology , Breast Neoplasms/metabolism , Camphor/pharmacology , Cinnamates/pharmacology , Female , Humans , Rats , Rats, Long-Evans , Tumor Cells, Cultured/drug effects
6.
J Endocrinol ; 166(1): 163-71, 2000 Jul.
Article in English | MEDLINE | ID: mdl-10856895

ABSTRACT

Peripheral benzodiazepine (BDZ) receptor (PBR) and diazepam-binding inhibitor/acyl-CoA-binding protein (DBI/ACBP) characterized as a ligand at central BDZ receptors, at PBR with involvement in the regulation of steroidogenesis, and as an intracellular acyl-CoA transporter, are both known to interact with BDZ in adult systems. We investigated their expression after prenatal exposure to BDZ. Diazepam (1.25 mg/kg per day s.c.) was administered to time-pregnant Long Evans rats from gestational day (GD) 14 to 20. Expression of mRNAs encoding for PBR and for DBI/ACBP was studied in the same animals with (33)P-labeled 60 mer oligonucleotides (oligos) by in situ hybridization at GD20, and with (32)P-labeled oligos by Northern blot in steroidogenic and immune organs at postnatal day (PN) 14 and in adult offspring. Prenatal diazepam increased DBI/ACBP mRNA expression in male fetal adrenal and in fetal and PN14 testis. Thymus exhibited increased DBI/ACBP mRNA in male fetuses and in adult female offspring, and reduced organ weight at PN14 in both sexes. In female spleen, an increase in DBI/ACBP mRNA and a decrease in PBR mRNA was seen at PN14. Apart from the finding in spleen, no drug-induced changes in PBR mRNA were observed. The effects of prenatal diazepam were superimposed on treatment-independent sex differences in DBI/ACBP mRNA and PBR mRNA expression. Our data indicate that expression of DBI/ACBP mRNA in steroidogenic and immune organs can be affected by exposure to BDZ during ontogeny, while PBR mRNA expression appears to be less sensitive. They further reveal marked sex differences in the developmental patterns of the two proteins during pre- and postpubertal ontogeny.


Subject(s)
Carrier Proteins/genetics , Diazepam/toxicity , Hypnotics and Sedatives/toxicity , Prenatal Exposure Delayed Effects , RNA, Messenger/analysis , Receptors, GABA-A/genetics , Adrenal Glands/embryology , Adrenal Glands/metabolism , Animals , Animals, Newborn , Blotting, Northern , Diazepam Binding Inhibitor , Female , In Situ Hybridization , Male , Organ Size/drug effects , Pregnancy , Rats , Rats, Long-Evans , Spleen/metabolism , Testis/embryology , Testis/metabolism , Thymus Gland/embryology , Thymus Gland/metabolism
7.
Toxicol Lett ; 115(1): 73-87, 2000 Apr 10.
Article in English | MEDLINE | ID: mdl-10817633

ABSTRACT

Developmental and adult toxicity of musk xylene was studied in Long Evans (LE) rats fed with chow containing musk xylene (MX) in food pellets in concentrations of 1 mg, 10 mg, 33 mg, 100 mg and 1000 mg MX per 1 kg chow corresponding to a daily intake of 0.07-0.08 mg MX/kg up to 70-80 mg MX/kg body weight. Adult male and female rats were MX exposed for a minimum of 10 weeks before mating. Exposure continued throughout pregnancy, birth and lactation. The effects of MX on CYP1A1/1A2 were studied in liver microsomes by EROD (7-ethoxyresorufin-rosomes deethylase) for CYP1A1 and by MROD (methoxyresorufin-o-demethylase) for CYP1A2 activity and by Western blotting. MX induced these enzymes dose dependently in adult and developing rats at PN (postnatal day) 1 and 14. The lowest effective maternal dose was 2-3 mg MX/kg/day. Western blot data of CYP2B and CYP3A indicated the induction of both P450 enzyme proteins in developing rats at PN 14 at the higher dose of 70-80 mg MX/kg/day. In contrast, upon high MX exposure CYP2B but not CYP3A was found to be induced in adult first generation male and female rats, indicating differential sensitivity to MX in development.


Subject(s)
Cytochrome P-450 Enzyme System/biosynthesis , Microsomes, Liver/drug effects , Xylenes/toxicity , Administration, Oral , Animals , Enzyme Induction , Female , Male , Microsomes, Liver/enzymology , Perfume/toxicity , Pregnancy , Prenatal Exposure Delayed Effects , Rats , Rats, Long-Evans , Water Pollutants, Chemical/toxicity , Xylenes/administration & dosage
8.
Toxicol Appl Pharmacol ; 158(3): 231-43, 1999 Aug 01.
Article in English | MEDLINE | ID: mdl-10438656

ABSTRACT

Polychlorinated biphenyls (PCBs) are lipophilic industrial chemicals which are regularly detected in human breast milk, serum, and tissues. They possess hormone-modulating properties, and, when transferred transplacentally to the developing fetus, PCBs have been shown to induce persistent sex-specific neurobehavioral deficits. Interactions of PCBs with sex steroid-modulated neural differentiation could in part account for such effects. To test this hypothesis, female Long-Evans rats were exposed via food containing 40 mg/kg of either a reconstituted PCB mixture (RM), composed according to the congener-pattern in human breast milk, or the technical PCB mixture Aroclor 1254 (A1254). The exposure period started 50 days prior to mating and was terminated at birth (postnatal day 0: PND 0). Aromatase (CYP 19) activity was determined in hypothalamus/preoptic area (HPOA) brain-sections from newborn male pups. This enzyme converts testosterone (T) to 17beta-estradiol (E(2)) and plays a key role in sexual brain differentiation. Moreover, serum concentrations of T and E(2), physical development, organ weights, exposure levels, and sex-specific behavior were evaluated at different life stages. On PND 0, a reduced aromatase activity was detected in the HPOA of male RM-pups compared to controls. Female RM-weanlings exhibited significantly elevated uterine wet weights on PND 21, which is a marker for estrogenic activity. In the adult stage (PND 170), male offspring with maternal exposure to either PCB mixture showed markedly reduced testes weights and serum testosterone levels, thus demonstrating persistent antiandrogenic effects. On PND 180, male RM-rats exhibited a behavioral feminization in a sweet preference test, suggesting long-lasting changes in neuronal brain organization caused by the perinatally suppressed aromatase activity. The results suggest that maternal exposure to the RM, the pattern of which is similar to the PCB spectrum in human milk, results in more distinct effects on sex steroid-dependent processes and behavior than the technical PCB mixture A1254. PCB levels in brain and adipose tissue of the exposed offspring lay within 1-2 orders of magnitude above background concentrations in humans.


Subject(s)
Aromatase/metabolism , Environmental Pollutants/toxicity , Food Preferences/drug effects , Gonadal Steroid Hormones/blood , Maternal Exposure/adverse effects , Polychlorinated Biphenyls/toxicity , Aging/physiology , Animals , Animals, Newborn , Birth Weight/drug effects , Brain/enzymology , Enzyme-Linked Immunosorbent Assay , Estradiol/blood , Female , Male , Organ Size/drug effects , Rats , Rats, Long-Evans , Saccharin/pharmacology , Sex Factors , Sweetening Agents/pharmacology , Testosterone/blood
9.
J Neuroendocrinol ; 11(2): 85-100, 1999 Feb.
Article in English | MEDLINE | ID: mdl-10048463

ABSTRACT

The Diazepam Binding Inhibitor/Acyl-CoA Binding Protein (DBI/ACBP) has been implicated in different functions, as acyl-CoA transporter and as an endogenous ligand at the GABA(A) receptor and the peripheral benzodiazepine receptor (PBR). The latter is thought to be involved in control of steroidogenesis. We studied the ontogeny of DBI/ACBP and PBR mRNA expression in embryos and offspring of time-pregnant Long Evans rats by in-situ hybridization with 33P-endlabelled oligonucleotides. Both mRNAs were present in embryo and placenta at gestational day (G)11, the earliest stage studied. DBI/ACBP mRNA was strongly expressed from embryonic through mid-foetal stages in central nervous system (maximum in neuroepithelium), cranial and sympathetic ganglia, anterior pituitary, adrenal cortex, thyroid, thymus, liver and (late foetal) brown adipose tissue, moderately in testis, heart, lung and kidney. In brain, a late foetal decrease of DBI/ACBP mRNA was followed by an increase at postnatal day 6. Peripheral benzodiazepine receptor mRNA expression started very low and increased to moderate levels in adrenal cortex and medulla, testis, thyroid, brown adipose tissue, liver, heart, lung, salivary gland at mid- to late-foetal stages. Data suggest a significant role of DBI/ACBP at early developmental stages. Both proteins may be involved in the control of foetal steroidogenesis. However, differences in developmental patterns indicate that additional functions may be equally important during ontogeny, such as the involvement in lipid metabolism in the case of DBI/ACBP.


Subject(s)
Acyl Coenzyme A/genetics , Brain Chemistry/physiology , Carrier Proteins/genetics , Receptors, GABA-A/genetics , Acyl Coenzyme A/metabolism , Adipose Tissue/chemistry , Adipose Tissue/embryology , Animals , Base Sequence , Brain/embryology , Carrier Proteins/metabolism , Diazepam Binding Inhibitor , Female , Fetus/chemistry , Fetus/metabolism , Gene Expression Regulation, Developmental , Molecular Sequence Data , Neurosecretory Systems/chemistry , Neurosecretory Systems/embryology , Oligonucleotide Probes , Pregnancy , RNA, Messenger/analysis , Rats , Rats, Long-Evans , Receptors, GABA-A/metabolism , Thymus Gland/chemistry , Thymus Gland/embryology
10.
Toxicol Lett ; 111(1-2): 117-32, 1999 Dec 20.
Article in English | MEDLINE | ID: mdl-10630707

ABSTRACT

Developmental and adult toxicity of musk xylene was studied in Long Evans (LE) rats fed with chow containing musk xylene (MX) in food pellets in concentrations of 1 mg, 10 mg, 33 mg, 100 mg and 1000 mg MX per 1 kg chow corresponding to a daily intake of 0.07-0.08 mg MX/kg up to 70-80 mg MX/kg body weight. Adult male and female rats were MX exposed for a minimum of 10 weeks before mating. Exposure continued throughout pregnancy, birth and lactation. The effects of MX on CYP1A1/1A2 were studied in liver microsomes by EROD (7-ethoxyresorufin-o-deethylase) for CYP1A1 and by MROD (methoxyresorufin-o-demethylase) for CYP1A2 activity and by Western blotting. MX induced these enzymes dose dependently in adult and developing rats at PN (postnatal day) 1 and 14. The lowest effective maternal dose was 2-3 mg MX/kg/day. Western blot data of CYP2B and CYP3A indicated the induction of both P450 enzyme proteins in developing rats at PN 14 at the higher dose of 70-80 mg MX/kg/day. In contrast, upon high MX exposure CYP2B but not CYP3A was found to be induced in adult first generation male and female rats, indicating differential sensitivity to MX in development.


Subject(s)
Cytochrome P-450 Enzyme System/biosynthesis , Enzyme Induction/drug effects , Fetus/drug effects , Perfume/toxicity , Water Pollutants, Chemical/toxicity , Xylenes/toxicity , Administration, Oral , Animals , Female , Male , Pregnancy , Rats , Rats, Long-Evans
11.
Peptides ; 19(8): 1317-27, 1998.
Article in English | MEDLINE | ID: mdl-9809645

ABSTRACT

The possibility of developmental effects of POMC-derived melanocortins and analogs on neurons of fetal rat brain regions exhibiting marked developmental melanocortin receptor expression, was studied in serum-free co-cultures of gestational day 18 striatal and mesencephalic cells, and compared with NEI and NGE. These two peptide fragments of the melanin concentrating hormone precursor, occurring in brain areas devoid of POMC terminals, cross-react with alpha-MSH antibodies; NEI elicits grooming similar to alpha-MSH. Neurofilament protein (NF), growth-associated protein (GAP-43) and synaptophysin of the synaptosomal fraction were determined by ELISA as markers for neuritogenesis, growth cones, and nerve terminal differentiation. Cell survival was analyzed by MTT assay, proportions of major cell types by immunocytochemistry. alpha-Melanocyte-stimulating hormone (alpha-MSH, effective concentration 250-2500 nM), the analog Nle4-, D-Phe7-alpha-MSH (NDP, 3.1-750 nM), and NEI (250 nM) increased NF in 3 day cultures by 11%, 17%, and 22%, respectively, whereas ACTH(1-24) and ACTH(1-39) (25 2500 nM) were ineffective. In 11 day cultures, alpha-MSH (250-750 nM), but not NDP, ACTH(1-24) or ACTH(1-39), increased synaptosomal synaptophysin by 11%. GAP-43 and cell survival remained unaffected. These data indicate that selected melanocortins as well as NEI can influence differentiation of neural processes in brain neurons.


Subject(s)
Corpus Striatum/growth & development , Melanocyte-Stimulating Hormones/analysis , Mesencephalon/growth & development , Oligopeptides/analysis , Peptide Fragments/analysis , Pituitary Hormones/analysis , Adrenocorticotropic Hormone/analysis , Animals , Brain/cytology , Brain/growth & development , Brain Chemistry , Cell Survival , Cells, Cultured , Coculture Techniques , Corpus Striatum/chemistry , Corpus Striatum/cytology , Culture Media, Serum-Free , Female , Fetus/cytology , GAP-43 Protein/analysis , Immunohistochemistry , Mesencephalon/chemistry , Mesencephalon/cytology , Neurofilament Proteins/analysis , Rats , Rats, Long-Evans , Synaptophysin/analysis
12.
Chemosphere ; 36(13): 2747-62, 1998 Jun.
Article in English | MEDLINE | ID: mdl-9745705

ABSTRACT

Bioaccumulation of musk xylene (MX) was measured by GC-ECD in adult and developing Long Evans rats. Males and females were fed with MX-containing chow (0.001, 0.01, 0.033, 0.1 g MX/kg food pellets) for 10 weeks before mating. Treatment continued during pregnancy and lactation. Offspring exhibited dose-dependent MX accumulation with 1/2-3/4 of adult female or 3-4 times adult male body fat levels (at 0.1 mg/kg food) at days 1 and 14. Milk levels were comparable to adult female adipose tissue. Data indicate significant transplacental passage and exposure via maternal milk. In rats fed with MX in adulthood, levels were highest in adipose tissue with significant amounts in other organs (ovary, adrenal). Female tissue levels were 3.7-6.8 times higher. This unexplained sex difference was unrelated to lipid content and was absent in offspring.


Subject(s)
Water Pollutants, Chemical/metabolism , Xylenes/metabolism , Adipose Tissue/metabolism , Animal Feed , Animals , Animals, Newborn , Chromatography, Gas , Female , Lactation , Male , Maternal-Fetal Exchange , Milk/chemistry , Pregnancy , Rats , Sex Factors , Tissue Distribution , Water Pollutants, Chemical/pharmacokinetics , Xylenes/pharmacokinetics
13.
J Neuroendocrinol ; 10(2): 133-46, 1998 Feb.
Article in English | MEDLINE | ID: mdl-9535059

ABSTRACT

Melanocortins are thought to be involved in neuronal development and regeneration. Pro-opiomelanocortin (POMC), the precursor of alpha-melanocyte stimulating hormone (alpha-MSH), gamma-MSH, ACTH, and beta-endorphin, becomes detectable in rat hypothalamic neurons from gestational day (E) 12.5. We recently described stage- and region-specific ontogenetic patterns of binding sites for the alpha-MSH analogue [125I]-Nle4,D-Phe7-alpha-MSH ([125I]-NDP), with the first localizations in epithalamus and sympathetic chain at E13. [125I]-NDP binds to all known melanocortin receptors, including MC3-R and MC4-R, the predominant melanocortin receptors in nervous system. To identify the receptor type expressed during ontogeny, the developmental pattern of MC3-R and MC4-R mRNA was investigated by in situ hybridization in fetuses and offspring of time-pregnant Long Evans rats between E14 and postnatal day (P) 27. MC4-R mRNA was found to be the predominant species during the entire fetal period. It was localized in all fetal areas exhibiting distinct [125I]-NDP binding, starting with sympathetic ganglia and epithalamus (E14), and including sensory trigeminal nuclei (E16), dorsal motor nucleus of vagus (E16) and cranial nerve ganglia, inferior olive (E18) and cerebellum (E18), striatal regions (E16), and entorhinal cortex (E22). In contrast, MC3-R mRNA was detectable only in the postnatal period, with a fast increase in expression in the ventromedial and arcuate nuclei. The early presence of MC4-R mRNA in central and peripheral nervous system and transient regional peaks of mRNA expression, often concomitant with periods of neural network formation, suggest a role of this receptor type in early ontogeny. The MC3 receptor may be involved in analogous processes during postnatal development.


Subject(s)
Nervous System/embryology , Nervous System/metabolism , RNA, Messenger/metabolism , Receptors, Corticotropin/biosynthesis , Amino Acid Sequence , Animals , Female , Male , Molecular Sequence Data , Nervous System/ultrastructure , Rats , Rats, Inbred Strains , Receptor, Melanocortin, Type 3 , Receptor, Melanocortin, Type 4
14.
Neuroendocrinology ; 66(3): 173-80, 1997 Sep.
Article in English | MEDLINE | ID: mdl-9380274

ABSTRACT

Sex differences in the activity of aromatase cytochrome P450 (CYP19) in the rat brain have been reported during pre- and postnatal development. It is unclear, however, whether these differences are reflected by corresponding differences in specific mRNA levels. To address this question, we have examined aromatase mRNA levels in specific regions of male and female rat brains by means of in situ hybridization (ISH). At prenatal stages of development, i.e. at gestational day 18 (GD18) and GD20, aromatase mRNA was detected in several preoptic, hypothalamic and limbic brain regions. Semiquantitative analysis of aromatase mRNA did not reveal sex differences in any of these regions. In contrast, clear-cut sex differences were determined at postnatal day (PN) 2; male animals expressed significantly more aromatase mRNA in the bed nucleus of stria terminalis (BST) and the sexually dimorphic nucleus of the preoptic area (SDN). Smaller but still significant differences (females > males) were obtained in the medial preoptic area (MPO). At PN6, sex differences of aromatase mRNA signals (males > females) were still present in the BST, but were no longer detectable in the SDN and the MPO. At PN15 and in adult animals, aromatase mRNA levels were similar in BST and medical amygdaloid nucleus of male and female rats. Since aromatase mRNA expression decreases during postnatal development, no ISH signals could be detected anymore in MPO, SDN and ventromedial hypothalamic nucleus. Our results are consistent with the concept that differential regulation of aromatase mRNA expression might be important for the establishment of different neuronal circuitry in male and female animals.


Subject(s)
Aromatase/genetics , Brain/metabolism , RNA, Messenger/biosynthesis , Sex Characteristics , Animals , Brain/embryology , Brain/growth & development , Embryonic and Fetal Development/physiology , Female , In Situ Hybridization , Male , Rats , Time Factors
15.
Melanoma Res ; 7(2): 117-9, 1997 Apr.
Article in English | MEDLINE | ID: mdl-9167177

ABSTRACT

D1 dopamine receptor mRNA has been demonstrated in mouse melanoma cells, and the expression of these G-protein-coupled receptors in human melanoma was therefore presumed when dopamine receptor binding radiopharmaceuticals were found to be useful for the detection of metastases in whole-body scintigraphy. The aim of this study was thus to investigate if D1 dopamine receptor mRNA or protein could be directly demonstrated in melanoma cells. The presence of D1 dopamine receptor mRNA was investigated in six human melanoma cell lines from metastases using reverse transcriptase-polymerase chain reaction (RT-PCR). In addition, in vitro binding assays with the D1 dopamine receptor agonist 125I-Sch 23982 were performed in 19 melanoma metastases. No D1 dopamine receptor mRNA could be detected by RT-PCR. All melanotic metastases were found to accumulate 125I-Sch 23982, with the presence of binding sites and intensity of 125I-Sch 23982 labelling correlating to the amount of melanin present in the metastases. Two amelanotic melanomas did not accumulate 125I-Sch 23982. D1 dopamine receptors could not be detected by means of RT-PCR or in vitro binding assays in human melanomas. Detection of antagonists is best explained by non-specific binding to melanin.


Subject(s)
Melanoma/metabolism , Receptors, Dopamine D1/biosynthesis , Animals , DNA Primers , Humans , Lymph Nodes/metabolism , Lymph Nodes/pathology , Lymphatic Metastasis , Melanoma/pathology , Mice , Polymerase Chain Reaction , RNA, Messenger/analysis , Receptors, Dopamine D1/analysis , Species Specificity , Tumor Cells, Cultured
16.
J Steroid Biochem Mol Biol ; 61(3-6): 359-64, 1997 Apr.
Article in English | MEDLINE | ID: mdl-9365211

ABSTRACT

Sex differences, androgen dependence and asymmetries of aromatase activity have been reported during ontogeny of the rat. It remains to be elucidated, however, whether the changes in aromatase activity are reflected by similar changes in specific mRNA levels. In addition, very little is known regarding mechanism(s) underlying such differential regulation of aromatase expression. To address these questions, we have employed the in situ hybridization (ISH) technique to examine specific mRNA levels in the brain of both male and female rats at selected stages of development. In prenatal stages of development, at gestational day (GD) 18 and 20, aromatase mRNA was detected in several hypothalamic and limbic brain regions. Semiquantitative analysis of aromatase mRNA did not reveal statistically significant sex differences in any of these regions (except in one experiment at GD20, when a sex difference was found in the medial preoptic nucleus). In contrast, clear sex differences were determined at postnatal day (PN) 2; male animals contained significantly more aromatase mRNA in the bed nucleus of the stria terminalis (BST) and the sexually dimorphic nucleus of the preoptic area (SDN) compared to female rats. Four days later in development, at PN6, sex differences of aromatase mRNA signals were observed in the BST, but were no longer detectable in the SDN. At PN15 and in adult animals, no sex differences could be determined. The effect of flutamide treatment (50 mg/kg/day) was investigated in GD20 fetuses as well as in adult rats. No statistically significant changes in aromatase mRNA expression were found in either case. In summary, our results suggest that differential regulation of aromatase mRNA expression during the critical period of sexual differentiation might, in part, account for the establishment of some of the many sexually dimorphic parameters of the rat brain. The role of androgens in the regulation of the sex-specific and developmental expression of aromatase mRNA in the rat brain remains to be clarified.


Subject(s)
Aromatase/physiology , Brain/enzymology , Gene Expression Regulation, Developmental/physiology , Gene Expression Regulation, Enzymologic/physiology , RNA, Messenger/analysis , Animals , Brain/embryology , Female , Male , Pregnancy , Rats , Sex Factors
17.
Brain Res Dev Brain Res ; 98(1): 114-24, 1997 Jan 02.
Article in English | MEDLINE | ID: mdl-9027410

ABSTRACT

In order to obtain information on the functional state of basal ganglia following prenatal benzodiazepine exposure, preprodynorphin mRNA expression and kappa-opioid receptors were studied in offspring of timed-pregnant Long Evans rats treated with diazepam (1.25 mg/kg/day) on gestational days 14 to 20. Preprodynorphin mRNA was localised by in situ hybridization using a 33P-labeled oligonucleotide. Relative optical density (ROD) was quantified by image analysis in four quadrants of caudate putamen, in nucleus accumbens and olfactory tubercle of adult male rats. Six hours after functional challenge by injection of D-amphetamine (8 mg/kg s.c.), prenatally vehicle-exposed rats exhibited increased preprodynorphin mRNA (ROD) levels in caudate putamen (dorsolateral 187%, dorsomedial 150%, ventrolateral 153%, ventromedial 140% of control), nucleus accumbens (142%) and olfactory tubercle (213%). Prenatal diazepam exposure attenuated the effect of amphetamine in all regions; statistically significant differences between ROD levels of prenatally vehicle/adult amphetamine-treated and prenatally diazepam/adult amphetamine-treated groups were seen in ventrolateral caudate putamen, nucleus accumbens and olfactory tubercle. Baseline levels and topographical distribution of preprodynorphin mRNA remained unchanged. kappa-opioid receptor binding was analyzed in membrane from nucleus accumbens + olfactory tubercle, caudate putamen, and midbrain of male and female offspring using [3h]U69593. Bmax was reduced in nucleus accumbens + olfactory tubercle, but not in caudate putamen or midbrain of adult, prenatally diazepam-exposed male offspring, This effect was not yet seen at earlier postnatal stages (14 and 28 days), and was also absent in females. These data indicate that prenatal exposure to diazepam results in a delayed change in the functional state of dynorphin-containing neurons in several parts of the basal ganglia of adult male offspring. The decreased responsiveness to enhanced dopaminergic transmissions may impair the function of basal ganglia circuitry.


Subject(s)
Amphetamine/pharmacology , Benzeneacetamides , Diazepam/pharmacology , Dynorphins/genetics , GABA Modulators/pharmacology , Prenatal Exposure Delayed Effects , Protein Precursors/genetics , Receptors, Opioid, kappa/metabolism , Sympathomimetics/pharmacology , Age Factors , Analgesics/pharmacology , Animals , Basal Ganglia/chemistry , Basal Ganglia/drug effects , Basal Ganglia/metabolism , Binding, Competitive/physiology , Female , Gene Expression/drug effects , In Situ Hybridization , Male , Pregnancy , Pyrrolidines/pharmacology , RNA, Messenger/metabolism , Rats , Rats, Inbred Strains , Receptors, Opioid, kappa/agonists , Tritium
18.
Brain Res ; 774(1-2): 184-92, 1997 Nov 07.
Article in English | MEDLINE | ID: mdl-9452207

ABSTRACT

The distribution of calcitonin receptor-like receptor (CRLR) mRNA in developing rats was investigated by in situ hybridization. Signals were found in the piriform cortex, the central and basolateral amygdala and the amygdalostriatal transition area. Among peripheral organs, the CRLR was predominantly expressed in the lung. mRNA expression in blood vessels, liver, midgut, rectum and urethra was restricted to gestational days 16 and/or 20. The CRLR was thought to be a calcitonin gene-related peptide (CGRP) type 1 receptor (Aiyar et al., J. Biol. Chem., 271 (1996) 11325-11329). This contrasts with previously reported evidence that the CRLR is an orphan receptor with no identifiable interactions with CGRP and other related ligands (Flühmann et al., Biochem. Biophys. Res. Commun., 206 (1995) 341-347). In situ hybridization signals have not been detected in the cerebellum and the spleen known to present a high density of CGRP binding sites. The different regional distribution of CGRP receptor binding sites and CRLR mRNA implies the latter encoding a different CGRP receptor subtype.


Subject(s)
Aging/metabolism , Animals, Newborn/metabolism , Fetus/metabolism , RNA, Messenger/metabolism , Receptors, Calcitonin/genetics , Animals , Embryonic and Fetal Development/physiology , In Situ Hybridization , Male , Rats , Rats, Inbred Strains
19.
Endocrinology ; 137(7): 2718-30, 1996 Jul.
Article in English | MEDLINE | ID: mdl-8770891

ABSTRACT

The physiological significance of androgens and neurosteroids in the development of the central nervous system (CNS) is still unclear. One way to address this question is to examine the regional and developmental expression of enzymes involved in the biosynthesis of these compounds. As 5alpha-reduction is a key step in the formation of dihydrotestosterone and some neurosteroids, we investigated the distribution of 5alpha-reductase (type 1) messenger RNA (mRNA) in the brain of fetuses and offspring of time pregnant Long-Evan rats by means of in situ hybridization. Our results indicate that during ontogeny, 5alpha-reductase mRNA is expressed in three distinct patterns. 1) During late embryonic and fetal development, on gestational days 12-18, specific 5alpha-reductase mRNA was detected in germinal and ventricular zones of the developing CNS. Specific labeling was also detected in the liver and certain ganglia, such as those of the trigeminal and spinal nerves. 2) During late fetal and early postnatal development, 5alpha-reductase mRNA levels in the ventricular zones gradually decreased, but specific mRNA newly appeared in differentiating regions of the brain, such as the cortical plate and the thalamus. 3) On postnatal day 15 and in adult animals, low levels of 5alpha-reductase mRNA were detected in typical white matter structures, such as optical chiasm, lateral olfactory tract, and corpus callosum. Expression of 5alpha-reductase mRNA in germinal zones and differentiating fields of the pre- and early postnatal rat CNS has not been described; this suggests that 5alpha-reductase might serve a function in general aspects of brain development, e.g. proliferation and differentiation. As several types of steroid hormones can serve as substrates for 5alpha-reductase, it remains to be elucidated which metabolite(s) mediates the possible actions of the_ enzyme in CNS development.


Subject(s)
3-Oxo-5-alpha-Steroid 4-Dehydrogenase/biosynthesis , Brain/enzymology , Embryonic and Fetal Development , Gene Expression Regulation, Developmental , Gene Expression Regulation, Enzymologic , RNA, Messenger/biosynthesis , Spinal Cord/enzymology , Aging/metabolism , Animals , Brain/embryology , Brain/growth & development , Female , Gestational Age , Oligonucleotides, Antisense , Organ Specificity , Placenta/enzymology , Pregnancy , Rats , Spinal Cord/embryology
20.
Brain Res Mol Brain Res ; 36(1): 127-36, 1996 Feb.
Article in English | MEDLINE | ID: mdl-9011748

ABSTRACT

Cloning and functional expression of a cDNA from the human cerebellum revealed a parathyroid hormone/parathyroid hormone-related peptide (PTH/PTHrP) receptor protein of 593 amino acids, identical in sequence to the PTH/PTHrP receptor of the human kidney and an osteoblast-like cell line (Schipani et al., Endocrinology, 132 (1993) 2157-2165). Expression of mRNA hybridizing with the cloned cDNA, indistinguishable in size on Northern blots from a 2.3 kb transcript in kidney and liver, was detected in eight brain areas. In situ hybridization histochemistry in rat brain tissue sections revealed predominant signals in the Purkinje cell layer of the cerebellum and in the mesencephalic nucleus of the trigeminal nerve. In human neuroblastoma (SK-N-MC) cells, stably transfected with the cloned cDNA, hPTH(1-84) and hPTH(1-34) displaced binding of 125 pM [125I][Tyr36]chPTHrP(1-36) to the PTH/PTHrP receptor with IC50 values of 4.0 +/- 0.6 nM and 2.00 +/- 0.08 nM, and stimulated cyclic AMP accumulation with EC50 values of 0.19 +/- 0.06 nM and 0.09 +/- 0.01 nM, respectively. 16 out of 48 cells responded to 100 nM hPTH(1-34) with a 2-10-fold transient increase of cytosolic free calcium concentrations. In conclusion, a PTH/PTHrP receptor, identified in the human cerebellum, has the primary structure of the corresponding receptors of kidney and bone. Expression in human neuroblastoma SK-N-MC cells revealed functional properties indistinguishable from those of non-neuronal tissues. The widespread distribution of PTHrP and its receptor in brain implies biological functions remaining to be elucidated.


Subject(s)
Cerebellum/chemistry , Neurons/chemistry , Parathyroid Hormone , Proteins/analysis , Receptors, Parathyroid Hormone/chemistry , Amino Acid Sequence , Base Sequence , Cloning, Molecular , Histocytochemistry , Humans , In Situ Hybridization , Molecular Sequence Data , Neuroblastoma , Parathyroid Hormone-Related Protein , Receptors, Parathyroid Hormone/physiology , Structure-Activity Relationship , Tumor Cells, Cultured
SELECTION OF CITATIONS
SEARCH DETAIL
...